HemoShear Therapeutics Names Biopharma Veteran Kathleen M. Metters, PhD, to Board of Directors
Metters Was Most Recently CEO of Lycera and Previously Led Worldwide Basic Research for Merck
CHARLOTTESVILLE, Va., June 19, 2019 -- (Healthcare Sales & Marketing Network) -- HemoShear Therapeutics, LLC, a privately held biotechnology company focused o... Biopharmaceuticals, Personnel HemoShear Therapeutics, REVEAL-Tx
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news